is tirzepatide a glp-1 agonist vs Semaglutide | Understanding The Differences GLP-1/GIP dual agonist tirzepatide normalizes
Description
At 72 weeks, patients on the combo regimen lost 22.1% of their body weight, with 92.8% of this weight loss attributable to fat loss
However, if you are someone with alcohol use disorder or a history of heavy drinking, this neurochemical shift is worth discussing with your healthcare provider
You know
Most competitors pair you with a provider and maybe a health coach
doi: 10.2337/cd23-0023
That might not sound like much, but at the 2.5mg starting dose, 1mg is 40% of your dose
